title: Essential thrombocytosis: diagnostic and treatment dilemmas.
abstract: Essential thrombocytosis is one of the chronic myeloproliferative disorders that includes polycythemia vera, chronic myelogenous leukemia, and agnogenic myeloid metaplasia. Despite established diagnostic criteria and greater than a quarter century of study, there are still several diagnostic and management dilemmas that plague researchers and clinicians alike. We present a case of essential thrombocytosis in a patient with multiple sequelae.
authors.affiliation: Department of Internal Medicine, Louisiana State University, School of Medicine, New Orleans, USA.
authors.forename: Veronica
authors.initials: V
authors.lastname: Dugan
authors.forename: Raphael
authors.initials: R
authors.lastname: Higginbotham
authors.forename: Jill
authors.initials: J
authors.lastname: Gilbert
authors.forename: Gary
authors.initials: G
authors.lastname: Lipscomb
authors.forename: Fred A
authors.initials: FA
authors.lastname: Lopez
mesh_terms: D001241:Aspirin / Q000627:therapeutic use; D002908:Chronic Disease; D006470:Hemorrhage / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D016898:Interferon-alpha / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011799:Quinazolines / Q000627:therapeutic use; D018570:Risk Assessment; D013922:Thrombocytosis / Q000150:complications / Q000175:diagnosis* / Q000628:therapy*; D034061:Thrombopoiesis / Q000502:physiology
chemical_list: D016898:Interferon-alpha; D011799:Quinazolines; C021139:anagrelide; D001241:Aspirin; D006918:Hydroxyurea